
PHARMANUTRA CS - DEPOSITO DEL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2023: directors' dealings · Italy · Consob
CONSOB:pharmanutra-cs-deposito-del-resoconto-intermedio-di-gestione-al-30-settembre-202ITIT·ConsobMcap 862M€Healthcare
Explore the full directors' dealings record of PHARMANUTRA CS - DEPOSITO DEL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2023, a listed equity based in Italy. Shares trade on IT IT, under the supervision of Consob. Operating in the Healthcare sector, PHARMANUTRA CS - DEPOSITO DEL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2023 has recorded 1 reports. Market capitalisation: €861.8m. The latest transaction was reported on 10 November 2023 — Other. Among the most active insiders: Unknown. The full history is free.
Financial data
FY ended December 2025 · cache
Analyst consensus
3 analysts76.00 €Target 81.33 €(-10%)86.00 €
Income statement
Revenue132.9 M€
Gross profit102.9 M€77% margin
Net income20.0 M€15.2% margin
Valuation
PER (trailing)40.9x
PER (forward)29.4x
P/Book12.1x
Balance sheet & cash
Market cap861.8 M€
Total debt20.5 M€
Free Cash Flow16.4 M€
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.1%
% insiders65.0%
% institutions16.1%
Last declaration on 10 November 2023